Home
>
US Stocks
>
Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc.
RYTM

Rhythm Pharmaceuticals Inc. (RYTM)

$11.19.09%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.03
Today Low/High
10.96 / 11.33
52 Week Low/High
$12.32 / $43.26
Market Cap
$653.69M

Company Details

Rhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for patients living with rare genetic diseases of obesity. Early-onset severe obesity may result from genetic variants within the melanocortin-4 receptor (MC4R) pathway, a key hypothalamic pathway that regulates hunger, caloric intake, and energy expenditure, consequently affecting body weight. Rhythm is developing setmelanotide for the treatment of rare genetic diseases of obesity that arise due to an impaired pathway, as setmelanotide has shown the potential to restore impaired pathway function.
Organisation
Rhythm Pharmaceuticals Inc.
Headquaters
Boston, Massachusetts, US
Employees
90
Industry
Health Technology
CEO
Hunter Smith

Discover more

Frequently Asked Questions

What is Rhythm Pharmaceuticals Inc. (RYTM) share price today?

Can Indians buy Rhythm Pharmaceuticals Inc. (RYTM) shares?

How can I buy Rhythm Pharmaceuticals Inc. (RYTM) shares from India?

Can Fractional shares of Rhythm Pharmaceuticals Inc. (RYTM) be purchased?

What are the documents required to start investing in Rhythm Pharmaceuticals Inc. (RYTM) stocks?

We are a SEBI registered investement advisor